281 related articles for article (PubMed ID: 30530780)
1.
Xiao W; Bharadwaj M; Levine M; Farnhoud N; Pastore F; Getta BM; Hultquist A; Famulare C; Medina JS; Patel MA; Gao Q; Lewis N; Pichardo J; Baik J; Shaffer B; Giralt S; Rampal R; Devlin S; Cimera R; Zhang Y; E Arcila M; Papaemmanuil E; Levine RL; Roshal M
Blood Adv; 2018 Dec; 2(23):3526-3539. PubMed ID: 30530780
[TBL] [Abstract][Full Text] [Related]
2. Genomic Landscape of Mixed-Phenotype Acute Leukemia.
Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
[TBL] [Abstract][Full Text] [Related]
3. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.
Weinberg OK; Seetharam M; Ren L; Alizadeh A; Arber DA
Am J Clin Pathol; 2014 Dec; 142(6):803-8. PubMed ID: 25389334
[TBL] [Abstract][Full Text] [Related]
4. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.
Takahashi K; Wang F; Morita K; Yan Y; Hu P; Zhao P; Zhar AA; Wu CJ; Gumbs C; Little L; Tippen S; Thornton R; Coyle M; Mendoza M; Thompson E; Zhang J; DiNardo CD; Jain N; Ravandi F; Cortes JE; Garcia-Manero G; Kornblau S; Andreeff M; Jabbour E; Bueso-Ramos C; Takaori-Kondo A; Konopleva M; Patel K; Kantarjian H; Futreal PA
Nat Commun; 2018 Jul; 9(1):2670. PubMed ID: 29991687
[TBL] [Abstract][Full Text] [Related]
5. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).
Khan M; Siddiqi R; Naqvi K
Ann Hematol; 2018 Jun; 97(6):945-953. PubMed ID: 29546454
[TBL] [Abstract][Full Text] [Related]
6. Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes.
Eckstein OS; Wang L; Punia JN; Kornblau SM; Andreeff M; Wheeler DA; Goodell MA; Rau RE
Exp Hematol; 2016 Aug; 44(8):740-4. PubMed ID: 27208809
[TBL] [Abstract][Full Text] [Related]
7. Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia.
Porwit A; Béné MC
Cytometry B Clin Cytom; 2019 May; 96(3):183-194. PubMed ID: 31033213
[TBL] [Abstract][Full Text] [Related]
8. Mixed-phenotypic acute leukemia series from tertiary care center.
Pawar RN; Banerjee S; Bramha S; Krishnan S; Bhattacharya A; Saha V; Chakrapani A; Bhave S; Chandy M; Nair R; Parihar M; Arora N; Mishra DK
Indian J Pathol Microbiol; 2017; 60(1):43-49. PubMed ID: 28195090
[TBL] [Abstract][Full Text] [Related]
9. Mixed-phenotype acute leukemia characteristics: first report from Iran.
Poopak B; Khosravi A; Bahoush-Mehdiabadi G; Madani T; Khodadi E; Farahani Z; Vahedi AA; Khosravipour G; Poopak P; Poopak AH
Clin Exp Med; 2018 Nov; 18(4):513-521. PubMed ID: 30019150
[TBL] [Abstract][Full Text] [Related]
10. Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing.
Quesada AE; Hu Z; Routbort MJ; Patel KP; Luthra R; Loghavi S; Zuo Z; Yin CC; Kanagal-Shamanna R; Wang SA; Jorgensen JL; Medeiros LJ; Ok CY
Oncotarget; 2018 Feb; 9(9):8441-8449. PubMed ID: 29492206
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of EGIL1998 and WHO2008 criteria for the diagnosis of mixed phenotype acute leukemia].
Ye L; Lin D; Mi YC; Zhang J; Wang Y; Wang HJ; Wei H; Liu BC; Zhou CL; Li W; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):286-90. PubMed ID: 22781719
[TBL] [Abstract][Full Text] [Related]
12. Acute leukemias of ambiguous lineage.
Béné MC; Porwit A
Semin Diagn Pathol; 2012 Feb; 29(1):12-8. PubMed ID: 22372202
[TBL] [Abstract][Full Text] [Related]
13. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
Rasekh EO; Osman R; Ibraheem D; Madney Y; Radwan E; Gameel A; Abdelhafiz A; Kamel A; Elfishawi S
Ann Hematol; 2021 Mar; 100(3):699-707. PubMed ID: 33230570
[TBL] [Abstract][Full Text] [Related]
14. Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations.
Mi X; Griffin G; Lee W; Patel S; Ohgami R; Ok CY; Wang S; Geyer JT; Xiao W; Roshal M; Garcia JS; Silverman LB; Sallan SE; Aster JC; Harris MH; Weinberg OK
Am J Hematol; 2018 Nov; 93(11):1358-1367. PubMed ID: 30117174
[TBL] [Abstract][Full Text] [Related]
15. [A study of mixed phenotype acute leukemia based on the 2008 World Health Organization classification].
Park J; Chae H; Kim M; Lim J; Kim Y; Lee J; Chung NG; Cho B; Kim HK; Lee S; Han K
Korean J Lab Med; 2010 Dec; 30(6):525-32. PubMed ID: 21157134
[TBL] [Abstract][Full Text] [Related]
16. DNMT3A (R882) mutation features and prognostic effect in acute myeloid leukemia in Coexistent with NPM1 and FLT3 mutations.
Kumar D; Mehta A; Panigrahi MK; Nath S; Saikia KK
Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):82-89. PubMed ID: 29079128
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of Mixed phenotype acute leukemia: experience from a tertiary oncology center.
Sukumaran R; Nair RA; Jacob PM; Nair Anila KA; Prem S; Binitha R; Kusumakumary P
Indian J Pathol Microbiol; 2015; 58(2):181-6. PubMed ID: 25885130
[TBL] [Abstract][Full Text] [Related]
18. Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India.
Rai V; Brahmbhatt B; Saha A; Thayakaran IP
Indian J Pathol Microbiol; 2024; 67(1):121-127. PubMed ID: 38358200
[TBL] [Abstract][Full Text] [Related]
19. Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
Orgel E; Alexander TB; Wood BL; Kahwash SB; Devidas M; Dai Y; Alonzo TA; Mullighan CG; Inaba H; Hunger SP; Raetz EA; Gamis AS; Rabin KR; Carroll AJ; Heerema NA; Berman JN; Woods WG; Loh ML; Zweidler-McKay PA; Horan JT;
Cancer; 2020 Feb; 126(3):593-601. PubMed ID: 31661160
[TBL] [Abstract][Full Text] [Related]
20. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
